Inscription Capital LLC Invests $3.01 Million in UnitedHealth Group Incorporated (NYSE:UNH)

Inscription Capital LLC purchased a new position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 6,087 shares of the healthcare conglomerate's stock, valued at approximately $3,011,000.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Capital & Planning LLC increased its position in shares of UnitedHealth Group by 19.2% in the fourth quarter. Capital & Planning LLC now owns 491 shares of the healthcare conglomerate's stock worth $248,000 after acquiring an additional 79 shares in the last quarter. Brighton Jones LLC raised its stake in UnitedHealth Group by 176.2% during the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock valued at $22,384,000 after purchasing an additional 28,231 shares during the period. Union Bancaire Privee UBP SA acquired a new stake in shares of UnitedHealth Group in the fourth quarter worth $27,233,000. Revolve Wealth Partners LLC raised its position in UnitedHealth Group by 137.1% during the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock valued at $2,033,000 after buying an additional 2,324 shares during the period. Finally, Bank Pictet & Cie Europe AG boosted its position in UnitedHealth Group by 3.9% during the 4th quarter. Bank Pictet & Cie Europe AG now owns 263,655 shares of the healthcare conglomerate's stock worth $133,373,000 after acquiring an additional 9,872 shares during the period. Institutional investors and hedge funds own 87.86% of the company's stock.

UnitedHealth Group Trading Down 1.8%

Shares of UnitedHealth Group stock opened at $307.84 on Tuesday. The company has a market cap of $279.25 billion, a price-to-earnings ratio of 19.86, a PEG ratio of 1.37 and a beta of 0.44. UnitedHealth Group Incorporated has a 1 year low of $248.88 and a 1 year high of $630.73. The company's fifty day simple moving average is $381.74 and its 200-day simple moving average is $470.20. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The company had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same period in the prior year, the company posted $6.91 EPS. As a group, sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th will be issued a $2.21 dividend. This represents a $8.84 annualized dividend and a yield of 2.87%. The ex-dividend date is Monday, June 16th. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's payout ratio is 37.02%.

Wall Street Analyst Weigh In

UNH has been the subject of several research reports. Deutsche Bank Aktiengesellschaft decreased their price target on shares of UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating for the company in a report on Wednesday, May 14th. Mizuho lowered their price target on shares of UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating on the stock in a report on Friday, May 16th. Royal Bank of Canada reduced their price objective on UnitedHealth Group from $525.00 to $355.00 and set an "outperform" rating for the company in a research report on Friday, May 16th. Bank of America downgraded UnitedHealth Group from a "buy" rating to a "neutral" rating and cut their price target for the stock from $560.00 to $350.00 in a research note on Wednesday, May 14th. Finally, TD Securities restated a "hold" rating and issued a $308.00 price objective (down previously from $520.00) on shares of UnitedHealth Group in a report on Monday, May 19th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have given a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $426.52.

Insider Activity

In other news, Director John H. Noseworthy purchased 300 shares of the business's stock in a transaction that occurred on Wednesday, May 14th. The stock was purchased at an average cost of $312.16 per share, with a total value of $93,648.00. Following the acquisition, the director now directly owns 6,063 shares of the company's stock, valued at approximately $1,892,626.08. This trade represents a 5.21% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Timothy Patrick Flynn acquired 1,533 shares of the firm's stock in a transaction on Wednesday, May 14th. The shares were purchased at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the purchase, the director now directly owns 6,033 shares of the company's stock, valued at approximately $1,935,386.40. The trade was a 34.07% increase in their position. The disclosure for this purchase can be found here. In the last three months, insiders have acquired 109,408 shares of company stock worth $31,607,768. Corporate insiders own 0.28% of the company's stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.